Alpha-defensins are small (3-4 kDa), cysteine-rich cationic peptides characterized by a conserved triple β-sheet structure stabilized by three disulfide bonds. Primarily secreted by neutrophils and Paneth cells, these peptides exhibit broad-spectrum antimicrobial activity against bacteria, fungi, and enveloped viruses via membrane disruption. Their cationic nature facilitates electrostatic attraction to negatively charged microbial membranes, forming voltage-dependent pores that induce osmotic lysis. Beyond direct pathogen killing, alpha-defensins (e.g., HNP1-3) promote neutrophil extracellular trap (NET) formation and modulate immune responses by enhancing phagocytosis, regulating cytokine production, and suppressing glucocorticoid-mediated immunosuppression.
Elevated alpha-defensin levels correlate with alcohol-related liver cirrhosis severity, where they predict hepatic encephalopathy and mortality. In prosthetic joint infections (PJI), synovial alpha-defensin detection via lateral flow assays achieves 92-100% specificity, serving as a rapid diagnostic biomarker. Genetic polymorphisms link alpha-defensin dysregulation to autoimmune disorders like lupus and neuropsychiatric conditions such as schizophrenia. Conversely, deficiencies increase susceptibility to pyogenic infections, particularly in immunocompromised individuals.
Common uses include IVD Assay standards, calibrators and controls, Immune system research.
GHS02, GHS05, GHS07
Danger
H226, H314, H318, H335
10 - Combustible Liquid
Flam. Liq. 3; Skin Skin Corr. 1A; Eye Dam. 1; STOT SE Resp. Irr. 3
P210, P243, P264+P265, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P333+P317, P501